TipRanks
Go Ultimate55% OFF

Novartis (NVSN) Revenue

Novartis Revenue

Novartis had a revenue of 15.03B in the quarter ending Sep 30, 2026, with 4.24%. This bring the company's revenue in the last twelve months to 56.31B, Increased 1.21%. In the fiscal year ending Dec 31, 2025, Novartis had annual revenue of 54.81B with 5.97% growth.

Revenue (ttm)
56.31B
Revenue Growth
-8.64%
P/S Ratio
101.88
Revenue/Employee
MXN 728,224
Employees
75,267
Market Cap
MXN 5.58T

Revenue Chart

Novartis Revenue - Annual

010B20B30B40B50B60B43.40B46.10B48.68B49.90B43.97B43.46B46.66B51.72B54.81B201720182019202020212022202320242025
Revenue History
Download to Excel
MX:NVSN revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202554.81B3.09B5.97%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.69B6.21%
Dec 31, 201743.40B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
MX:NVSN56.31B
LLY86.46B
JNJ99.33B
MRK66.40B
PFE63.70B
SNY48.92B